Predicting Autoimmunity Following Treatment of Multiple Sclerosis with Alemtuzumab

被引：1
|
作者：
Jones, Joanne [1 ]
Compston, Alastair [1 ]
Coles, Alasdair [1 ]
机构：
[1] Univ Cambridge, Cambridge, England
来源：
CLINICAL IMMUNOLOGY | 2010年 / 135卷
关键词：
D O I：
10.1016/j.clim.2010.03.310
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
引用
收藏
页码：S103 / S103
页数：1
相关论文
共 50 条
  • [31] A case of fulminant Goodpasture syndrome following alemtuzumab treatment for multiple sclerosis
    Lapointe, E.
    Moghaddam, B.
    Barclay, K.
    Neufeld, P.
    Phelps, R.
    Traboulsee, A.
    MULTIPLE SCLEROSIS JOURNAL, 2017, 23 : 640 - 640
  • [32] A case of leukocytoclastic vasculitis in a multiple sclerosis patient following alemtuzumab treatment
    Edwards, Keith R.
    Lezcano, Cecilia
    Spiro, Joel
    Siuta, Jessica
    Kamath, Vineetha
    MULTIPLE SCLEROSIS JOURNAL, 2017, 23 (01) : 34 - 34
  • [33] An unforeseen reality: Hemophagocytic lymphohistiocytosis following alemtuzumab treatment for a multiple sclerosis
    Osep, Anka Blagotinsek
    Brecl, Eva
    Skerget, Matevz
    Savsek, Lina
    CLINICAL NEUROLOGY AND NEUROSURGERY, 2023, 228
  • [34] Severe paradoxical disease activation following alemtuzumab treatment for multiple sclerosis
    Brannigan, Jamie
    Jones, Joanne L.
    Stacpoole, Sybil R. L.
    NEUROLOGY-NEUROIMMUNOLOGY & NEUROINFLAMMATION, 2020, 7 (05):
  • [35] Can induction of autoimmune antibodies after alemtuzumab treatment of multiple sclerosis predict secondary autoimmunity?
    Sandgren, S.
    Novakova, L.
    Axelsson, M.
    Amirbeagi, F.
    Kockum, I.
    Olsson, T.
    Malmestrom, C.
    Lycke, J.
    MULTIPLE SCLEROSIS JOURNAL, 2021, 27 (2_SUPPL) : 637 - 637
  • [36] Autoimmunity in patients treated with alemtuzumab for relapsing-remitting multiple sclerosis
    Fox, E. J.
    Arnold, D. L.
    Cohen, J.
    Coles, A. J.
    Confavreux, C.
    Hartung, H. -P.
    Havrdova, E.
    Selmaj, K.
    Weiner, H.
    Lake, S. L.
    Margolin, D. H.
    Oyuela, P.
    Panzara, M.
    Compston, D. A. S.
    MULTIPLE SCLEROSIS JOURNAL, 2012, 18 : 465 - 466
  • [37] Alopecia Universalis following Alemtuzumab Treatment in Multiple Sclerosis: A Barely Recognized Manifestation of Secondary Autoimmunity-Report of a Case and Review of the Literature
    Zimmermann, Julian
    Buhl, Timo
    Mueller, Marcus
    FRONTIERS IN NEUROLOGY, 2017, 8
  • [38] The role of alemtuzumab in the development of secondary autoimmunity in multiple Sclerosis: a systematic review
    Jimenez-Sanchez, Sofia
    Maksoud, Rebekah
    Eaton-Fitch, Natalie
    Marshall-Gradisnik, Sonya
    Broadley, Simon A.
    JOURNAL OF NEUROINFLAMMATION, 2024, 21 (01)
  • [39] Alopecia totalis following alemtuzumab treatment in relapsing-remitting multiple sclerosis
    Zimmermann, J.
    Buhl, T.
    Mueller, M.
    MULTIPLE SCLEROSIS JOURNAL, 2017, 23 : 382 - 382
  • [40] Acute respiratory distress syndrome following treatment with alemtuzumab for relapsing multiple sclerosis
    Pace, A.
    Jackson, F.
    Lusher, W.
    Mihalova, T.
    Sharaf, N.
    Rog, D.
    Talbot, P.
    MULTIPLE SCLEROSIS JOURNAL, 2016, 22 : 318 - 319
12345